(Press-News.org)
Studying a person’s genetic makeup can predict if they will go on to develop invasive breast cancer after abnormal cells have been found in their breast tissue.
For the first time, researchers at King’s College London have shown the connection between a person’s genetic risk score and their risk of developing the disease after irregular cells have been detected.
The research, published in Cancer Epidemiology, Biomarkers & Prevention and funded by Breast Cancer Now, included over 2,000 women in the UK who had been tested for 313 genetic changes, known as a genetic risk score.
These patients had already been diagnosed with either ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS) – the most common types of abnormal cells found in breast tissue.
A genetic risk score estimates a person's inherited likelihood of developing a disease or trait by combining the influence of multiple common genetic variants.
Screening allows breast cancers to be caught at an earlier stage and is typically offered every three years to women aged 50 to 71 via the NHS Breast Screening Programme.
However, this has led to a large number of women being diagnosed with abnormal cells in their breast tissue which are not invasive cancer but may become cancer in the future.
At the moment it is not possible to know which women with abnormal cells will go on to develop invasive breast cancer, so they are offered a variety of treatments.
This can range from increased surveillance to surgery, radiotherapy and anti-estrogen therapy.
Breast cancer is the most common cancer in women, with around 55,000 women diagnosed each year in the UK. The earlier breast cancer is diagnosed, the better the chance of successful treatment so being able to predict who might be at risk is crucial.
Jasmine Timbres, first author and Clinical Information Analyst at King’s College London, said “Our initial results are very promising. Predicting who is most likely to develop invasive breast cancer is vital to offering the best possible treatment options for women, as not all with DCIS or LCIS will go on to develop invasive cancer.
The results of this study show that the genetic risk score could be useful in this prediction, meaning that treatments could be more personalised, rather than giving everyone the same treatment approach. In some cases, this could avoid unnecessary invasive treatments altogether, which can take a toll on patients both physically and emotionally. Focusing more on individual risk could improve overall well-being and help reduce the stress that comes with being overtreated.”
Professor Elinor Sawyer, senior author and a Consultant Clinical Oncologist at King’s College London, said:
"In my clinical practice, I see many women diagnosed with DCIS or LCIS. Until now, treatment decisions have mostly been based on how the cells look under a microscope. Our research shows that a genetic risk score can also help predict which women are more likely to develop invasive breast cancer.
“This means we shouldn't just focus on the cells themselves, but also take into account a woman’s genetic risk and lifestyle factors. By looking at the full picture, we can give women more accurate information about their personal risk of recurrence. This helps them make more informed choices about their treatment options and what’s right for them.”
Dr Simon Vincent, chief scientific officer at Breast Cancer Now, said: “This study offers evidence that genetic risk scoring could be a useful tool for predicting future breast cancer in women diagnosed with ductal carcinoma in situ or lobular carcinoma in situ – which are the most common pre-invasive abnormal cells found in the breast. Understanding who is most likely to develop invasive disease in the future could help to tailor care for those most at risk, inform treatment decisions and improve individual wellbeing for women.
“While these initial findings show promise for paving the way for more personalised treatment decisions in the future, more research is needed before this test can be used more widely."
END
Genetic test can predict who could develop invasive breast cancer
2025-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Uncovering the molecular basis of long COVID brain fog
2025-10-01
Even though many years have passed since the start of the COVID-19 pandemic, the effects of infection with SARS-CoV-2 are not completely understood. This is especially true for Long COVID, a chronic condition that can develop after COVID-19 that causes a variety of lasting symptoms. Among the most common and debilitating of these is cognitive impairment, often referred to as “brain fog,” which affects over 80% of people with Long COVID. Given the hundreds of millions of global cases, Long COVID represents a massive public health and socioeconomic challenge, as it severely ...
Poor sleep may accelerate brain ageing
2025-10-01
People who sleep poorly are more likely than others to have brains that appear older than they actually are. This is according to a comprehensive brain imaging study from Karolinska Institutet, published in the journal eBioMedicine. Increased inflammation in the body may partly explain the association.
Poor sleep has been linked to dementia, but it is unclear whether unhealthy sleep habits contribute to the development of dementia or whether they are rather early symptoms of the disease. In a new study, researchers at Karolinska Institutet have investigated the link between sleep characteristics and how old the brain appears in relation ...
The Lancet Infectious Diseases: New study suggests risk of long COVID in children may be twice as high after a second infection
2025-09-30
A new study published in The Lancet Infectious Diseases involving over 460,000 children and adolescents across 40 paediatric hospitals in the USA suggests that children who were infected with COVID-19 for the second time during the Omicron wave had more than double the risk of developing long COVID.
Conducted by researchers under the US National Institutes of Health (NIH)-funded RECOVER Initiative*, this is the largest study to date examining the long-term effects of COVID-19 reinfection in young people. The study analysed electronic ...
Risk of long COVID in kids doubles after second infection
2025-09-30
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, according to a large study funded by the National Institutes of Health (NIH) and published in Lancet Infectious Diseases. These results run counter to the popular perceptions that COVID in children is "mild" and that reinfections with COVID do not carry the same risk of long COVID that initial infections do.
Among the conditions ...
Patient-reported outcome analysis of NRG Oncology trial in limited-stage small cell lung cancer suggests quality of life benefit with twice - (vs once -) daily radiation
2025-09-30
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell lung cancer was reported at the American Society for Radiation Oncology 2024 Annual Meeting. Those results showed that adding atezolizumab did not improve overall survival (OS) for this patient population. At the same time, an exploratory analysis reported longer median OS among patients who received twice-a-day radiation, though RT schedule was ...
NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III
2025-09-30
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) for patients with newly diagnosed glioblastoma (GBM). The recent analysis of the proton cohort revealed improved survival for patients receiving proton therapy at 75 Gy. Because this data met the pre-defined survival improvement threshold, they could be used to design and conduct a definitive phase III randomized ...
In a landmark move, ECMWF is poised to announce a new phase in its data sharing strategy
2025-09-30
As part of its strategy and ongoing commitment to open science, ECMWF (The European Centre for Medium-Range Weather Forecasts) has been opening its extensive data catalogue and making its science more widely open and accessible.
The organisation holds one of the world’s largest meteorological archives, exceeding 1.3 exabytes of data. Starting with historical data and charts, and ECMWF is now moving to make real-time forecast data openly available. By making its data openly available, ECMWF is supporting the UN’s Early Warnings for All initiative and enabling societies ...
Seal’s sensitive whiskers hold key to foiling fish escapes
2025-09-30
Life beneath the waves can be a game of cat and mouse. Seals pursue swimming fish by following the tell-tale wakes and spinning vortices they leave behind, sensing the faint swirls with their sensitive whiskers. But fish might have a trick up their sleeves. Yvonne Krüger from University of Rostock, Germany, explains that escaping fish produce three jets of different sizes they dart away, squirting in individual directions almost simultaneously – at least two of which form into vortex rings, like smoke rings – which could confuse a seal. But might seals be able to see through the ...
Neurological outcomes after patients suffer cardiac arrest at home are similar between low- and high-income areas in Vienna
2025-09-30
Vienna, Austria: People who have a cardiac arrest in their own homes have similar neurological outcomes regardless of socioeconomic background, according to research presented at the European Emergency Medicine Congress today (Wednesday) [1].
However, the study of 676 patients who received treatment in the Department of Emergency Medicine at the Medical University of Vienna suggested that those who lived in lower-income areas may be less likely to receive cardiopulmonary resuscitation (CPR) from bystanders compared to people suffering a cardiac arrest (when the heart stops pumping blood around the body) in higher-income areas – a finding ...
Precision without incision: the new era of functional radiosurgery
2025-09-30
MIAMI, FLORIDA (Sept. 30, 2025) -- Research findings from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, are being presented this week at ASTRO 2025 – the American Society for Radiation Oncology’s annual meeting in San Francisco.
Markus Bredel, M.D., Ph.D., professor and chair of the Miller School’s Department of Radiation Oncology, presented at the Presidential Symposium, focusing on “Precision Without Incision: The New Era of Functional Radiosurgery.” His session, “Classical Movement Disorders and Connectomics: Image-Guided ...